In this episode, you'll hear a conversation with our own Vonda McAllister about the critical role of rapid diagnostic testing in helping prevent drug overdose deaths. Discover how early detection in emergency departments enables timely interventions when patients present with altered mental status or respiratory distress. The discussion explores the evolving landscape of substance abuse in 2025, including synthetic opioids like fentanyl, emerging threats like xylazine ("tranq") and the challenges of polydrug use, creating unpredictable and potentially fatal combinations.

About Our Speaker: 

Vonda McAllister, Director of Global Product Management. Vonda's diagnostic experience spans from R&D and program management to marketing. Now a member of the Point of Care business unit, she previously managed the Triage™ portfolio of assays and the clinical labs team for North America. Vonda is currently focused on supporting the global regions with our PlGF tests, that is, placental growth factor, and toxicology assays, as well as expanding the Triage toxicology and women's health testing portfolio. She also serves as global leadership co-chair for the QuidelOrtho Women's Leadership Network.